000 01065 a2200277 4500
005 20250517162810.0
264 0 _c20180329
008 201803s 0 0 eng d
022 _a2159-8290
024 7 _a10.1158/2159-8290.CD-17-0481
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSinha, Seema
245 0 0 _aThe Path of Most Resistance: Transdifferentiation Underlies Exceptional Nonresponses to Androgen Receptor Pathway Inhibition in Prostate Cancer.
_h[electronic resource]
260 _bCancer discovery
_c07 2017
300 _a673-674 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aCell Transdifferentiation
_xdrug effects
650 0 4 _aDrug Resistance, Neoplasm
_xgenetics
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aProstatic Neoplasms
_xdrug therapy
650 0 4 _aReceptors, Androgen
_xdrug effects
700 1 _aNelson, Peter S
773 0 _tCancer discovery
_gvol. 7
_gno. 7
_gp. 673-674
856 4 0 _uhttps://doi.org/10.1158/2159-8290.CD-17-0481
_zAvailable from publisher's website
999 _c27345057
_d27345057